Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 Aug;16(2):210–213. doi: 10.1128/aac.16.2.210

New Rapid Assay for Nafcillin in Serum by Spectrofluorometry

Diane M Lichtenwalner 1, Byungse Suh 1, Bennett Lorber 1, Alan M Sugar 1
PMCID: PMC352823  PMID: 485130

Abstract

A new, rapid method for measuring serum levels of nafcillin by spectrofluorometry is described. The method involves extraction of 2 ml of acidified serum with n-butyl chloride, subjecting the organic solvent layer to excitation at 340 nm, and measuring the relative intensity of emission fluorescence at 380 nm. An excellent linear correlation exists between serum levels of nafcillin and the relative intensity in a drug concentration range of 0.25 to 150 μg/ml. The results obtained by this spectrofluorometric technique are in complete accord with those obtained by the conventional microbiological assay using Staphylococcus aureus ATCC 6538P. The method is not interfered with by elevated levels of endogenous metabolic products or the presence of other drugs, including a number of antimicrobial agents. The assay is interfered with, however, by the presence of salicylates, for which appropriate correction can easily be made. A salicylate assay employing a spectrofluorometric technique is also described.

Full text

PDF
210

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Diaz C. R., Kane J. G., Parker R. H., Pelsor F. R. Pharmacokinetics of nafcillin in patients with renal failure. Antimicrob Agents Chemother. 1977 Jul;12(1):98–101. doi: 10.1128/aac.12.1.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fossieck B. E., Jr, Kane J. G., Diaz C. R., Parker R. H. Nafcillin entry into human cerebrospinal fluid. Antimicrob Agents Chemother. 1977 Jun;11(6):965–967. doi: 10.1128/aac.11.6.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Friedman H., Warren G. H. Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin. Proc Soc Exp Biol Med. 1974 Jul;146(3):707–711. doi: 10.3181/00379727-146-38177. [DOI] [PubMed] [Google Scholar]
  4. Kancir L. M., Tuazon C. U., Cardella T. A., Sheagren J. N. Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureaus infections. Arch Intern Med. 1978 Jun;138(6):909–911. [PubMed] [Google Scholar]
  5. Kane J. G., Parker R. H., Jordan G. W., Hoeprich P. D. Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Ann Intern Med. 1977 Sep;87(3):309–311. doi: 10.7326/0003-4819-87-3-309. [DOI] [PubMed] [Google Scholar]
  6. Ruiz D. E., Warner J. F. Nafcillin treatment of Staphylococcus aureus meningitis. Antimicrob Agents Chemother. 1976 Mar;9(3):554–555. doi: 10.1128/aac.9.3.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. TRINDER P. Rapid determination of salicylate in biological fluids. Biochem J. 1954 Jun;57(2):301–303. doi: 10.1042/bj0570301. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES